Dimensional Fund Advisors LP Aldeyra Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 604,041 shares of ALDX stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

604,041

Previous 672,057 10.12%

Holding current value

$2.91 Million

Previous $2.22 Million 46.36%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.19 - $6.32 $216,971 - $429,861	-68,016 Reduced 10.12%	604,041 $3.26 Million
Q2 2024 Aug 09, 2024	SELL	$3.25 - $4.72 $682,997 - $991,922	-210,153 Reduced 23.82%	672,057 $2.22 Million
Q1 2024 May 10, 2024	SELL	$2.77 - $4.22 $433,344 - $660,185	-156,442 Reduced 15.06%	882,210 $2.88 Million
Q4 2023 Feb 07, 2024	SELL	$1.47 - $6.06 $244,566 - $1.01 Million	-166,372 Reduced 13.81%	1,038,652 $3.65 Million
Q3 2023 Nov 09, 2023	BUY	$6.11 - $8.16 $485,005 - $647,732	79,379 Added 7.05%	1,205,024 $8.05 Million
Q2 2023 Aug 09, 2023	BUY	$7.11 - $11.89 $19,460 - $32,542	2,737 Added 0.24%	1,125,645 $9.44 Million
Q1 2023 May 12, 2023	BUY	$5.77 - $9.93 $1.34 Million - $2.31 Million	232,676 Added 26.14%	1,122,908 $11.2 Million
Q4 2022 Feb 09, 2023	BUY	$5.08 - $7.09 $1.07 Million - $1.49 Million	210,219 Added 30.91%	890,232 $6.2 Million
Q3 2022 Nov 10, 2022	BUY	$3.8 - $7.74 $2.27 Million - $4.62 Million	597,093 Added 720.08%	680,013 $3.63 Million
Q2 2022 Aug 12, 2022	SELL	$2.43 - $4.85 $205,818 - $410,790	-84,699 Reduced 50.53%	82,920 $331,000
Q1 2022 May 13, 2022	SELL	$3.25 - $5.17 $298,996 - $475,634	-91,999 Reduced 35.44%	167,619 $745,000
Q4 2021 Feb 09, 2022	SELL	$3.5 - $9.63 $41,181 - $113,306	-11,766 Reduced 4.34%	259,618 $1.04 Million
Q2 2021 Aug 12, 2021	SELL	$10.44 - $14.85 $36,028 - $51,247	-3,451 Reduced 1.26%	271,384 $3.08 Million
Q1 2021 May 14, 2021	BUY	$6.53 - $14.42 $44,423 - $98,099	6,803 Added 2.54%	274,835 $3.27 Million
Q4 2020 Feb 25, 2021	BUY	$6.31 - $8.13 $1.69 Million - $2.18 Million	268,032 New	268,032 $1.84 Million

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $281M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Aldeyra Therapeutics, Inc. Transaction History